Complicated Appendicitis During the COVID-19 Pandemic in Jordan

May 13, 2022 updated by: Abdallah Raed Al-Qawasmeh, Jordan University Hospital

Impact of the COVID-19 Pandemic on the Incidence of Complicated Appendicitis in a Tertiary Medical Center, Amman, Jordan: A Retrospective Cohort

Comparing the incidence of complicated appendicitis between two groups, the pandemic and pre-pandemic groups.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators have retrospectively investigated data on acute appendicitis cases. Two groups were established, the first group was the pandemic group, which included patients who presented to the hospital during the period of acute restrictions and shutdowns extending from the 17th of March to the 6th of June 2020, and the pre-pandemic group which represents the same period in the previous year, the aim was to assess the incidence of complicated appendicitis during the COVID-19 pandemic in Jordan University Hospital

Study Type

Observational

Enrollment (Actual)

257

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Jordan
      • Amman, Jordan, 11942
        • Jordan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Any patient that has a medical record for appendicitis and underwent appendectomy at University of Jordan hospital

Description

Inclusion Criteria:

  • Any patient that presented with appendicitis and underwent an appendectomy at the university of Jordan hospital during the specified time periods (March 2019-December 2020)

Exclusion Criteria:

  • Incomplete data record.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
pandemic group (2020)
includes patients who presented to the hospital during the period of acute restrictions and shutdowns extending from the 17th of March to the 6th of June 2020
Other: Observational Study
Observational Study; the study did not involve any interventions
pre-pandemic group (2019)
which represents the same period in the previous year

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of postoperative complications
Time Frame: Up to 2 years
To determine if there were any complications, this was detected by reviewing the histopathology report
Up to 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of in-hospital stay
Time Frame: Up to 2 years
How many days did the patient spend in the hospital until discharged.
Up to 2 years
Imaging method used for diagnosis (CT or US)
Time Frame: Up to 2 years
How was appendicitis diagnosed, either by using Computed Tomography (CT) Scan or Ultrasound.
Up to 2 years
Type of operation (open or laparoscopic)
Time Frame: Up to 2 years
We reported what type of operation the patient underwent to treat appendicitis.
Up to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Jordan University Hospital

Investigators

  • Principal Investigator: Marzouq Amarin, MD, MSc, Department of General Surgery, the University of Jordan, Amman, 11942, Jordan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2019

Primary Completion (Actual)

December 28, 2020

Study Completion (Actual)

December 28, 2020

Study Registration Dates

First Submitted

May 11, 2022

First Submitted That Met QC Criteria

May 13, 2022

First Posted (Actual)

May 16, 2022

Study Record Updates

Last Update Posted (Actual)

May 16, 2022

Last Update Submitted That Met QC Criteria

May 13, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 28/2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on Observational Study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe